Articles Companion animals

23 July 2026

Renoprotective effects of curcumin in cats with chronic kidney disease.

Clinical evidence update from Journal of veterinary internal medicine

Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for feline patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in Journal of veterinary internal medicine in 2026 evaluated renoprotective effects of curcumin in cats with chronic kidney disease..

Key Findings

Chronic kidney disease (CKD) in cats is characterized by oxidative stress, inflammation, and apoptosis. Curcumin has shown renoprotective effects in experimental models, but clinical evidence in cats with CKD remains limited. Evaluate whether PO curcumin supplementation (80 mg/cat/day), administered with standard treatment, favorably modulates renal, oxidative, inflammatory, and apoptotic biomarkers in cats with International Renal Interest Society (IRIS) stage 3 CKD. Sixteen client-owned cats with IRIS stage 3 CKD. Prospective, randomized trial. Cats were allocated to medical treatment alone (MT; n = 8) or medical treatment plus curcumin...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for feline patients.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

Read the full article here.

Like0

Dislike0

List
Add

Please enter a comment

Name *

Email address *

Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

Dislike0

News of interest

Multilevel analysis of risk factors for clinical mastitis in dairy cows in Plateau State, Nigeria a hierarchical mixed-effects logistic regression modelling approach.

Strategies for Reducing Antimicrobial Use in Cattle Through Gut Microbiome Modulation A Systematic Review of Alternatives to Antibiotics.

Long term safety and efficacy of a functionalized nanogel with endothelin-1 and bradykinin receptor antagonist peptides for treatment of osteoarthritis of the metacarpophalangeal and distal interphalangeal joints in horses

Exploration of the efficacy of eucalyptus oil (micro-capsules) and mangosteen extract against Eimeria tenella infection in chickens.

EVENTS

Edrapublishing

About Us Authors Contact Us Legal Notes Privacy Search

Top

Renoprotective effects of curcumin in cats with chronic kidney disease.

Clinical evidence update from Journal of veterinary internal medicine

Comments

List

Add

Tag

Related Articles

22 July 2026
The combination of lomustine and corticosteroids is a valid chemotherapeutic option in cats with presumptive central nervous system lymphoma.

The combination of lomustine and corticosteroids is a valid chemotherapeutic option in cats with presumptive central nervous system lymphoma.

22 July 2026
Efficacy of Oral Baicalin in Canine Atopic Dermatitis A Randomised Placebo Controlled Trial.

Efficacy of Oral Baicalin in Canine Atopic Dermatitis A Randomised Placebo Controlled Trial.

22 July 2026
Efficacy of dietary onion powder (Allium cepa L.) as a phytogenic feed additive Effects on growth performance, blood biochemistry, gut morphology, and immune function in broiler chickens.

Efficacy of dietary onion powder (Allium cepa L.) as a phytogenic feed additive Effects on growth performance, blood biochemistry, gut morphology, and immune function in broiler chickens.

21 July 2026
Ultrasonographic characteristics of renal lymphoma in cats receiving chemotherapy.

Ultrasonographic characteristics of renal lymphoma in cats receiving chemotherapy.

21 July 2026
A potential risk factor associated with acute tumor lysis syndrome in dogs with multicentric lymphoma receiving chemotherapy.

A potential risk factor associated with acute tumor lysis syndrome in dogs with multicentric lymphoma receiving chemotherapy.

More news

Welcome Dr. JeanMarie Cavillo, microbiologist, Washington Animal Disease Diagnostic Laboratory

Latest News and Press Releases

An Open-Label Split-Body Clinical Trial Evaluating Therapeutic Efficacy and Safety of Cold Atmospheric Plasma in Canine Acute Otitis Externa.

Seroprevalence of Q-fever among domestic ruminants, humans and ticks in Ethiopia A systematic review and meta-analysis.

Tiny Molecules, Big Possibilities: Texas A&M Researchers Explore A New Way To Slow Lung Cancer

Newsletter